Later, the homozygous variant p.G229C in the DLD gene was identified to be causative for this hepatic phenotype of DLDD [5] which was shown to be a founder mutation among Ashkenazi Jews with a homozygosity rate of 1:35.000 newborns [5]. This evidence concerns the gene DLD and pyruvate dehydrogenase E3 deficiency.